Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke
NCT ID: NCT00710164
Last Updated: 2010-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
130 participants
INTERVENTIONAL
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Yiqi Huoxue Demolition and Recipes on Recovery Stage of Cerebral Infarction
NCT02846207
Proteomic Study of Chuanhong Zhongfeng Capsule in the Treatment of ACI
NCT06874140
Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke
NCT05731310
Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke
NCT00817609
Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM
NCT02334969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
XSCR capsule (Composed of Traditional Chinese Medicine Huangqi, Chuanxiong, Chishao, Danggui, Dilong, Taoren, Honghua.)
14 days of XSCR capsule
B
Placebo
14 days of Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
XSCR capsule (Composed of Traditional Chinese Medicine Huangqi, Chuanxiong, Chishao, Danggui, Dilong, Taoren, Honghua.)
14 days of XSCR capsule
Placebo
14 days of Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Onset of symptoms within 72 hours
* 18 Years and older
* Consistent with the Qi deficiency and Blood stasis type by Traditional Chinese Medicine (TCM) standard
* Patients or their representatives voluntarily take part in this study and signed the informed consent
Exclusion Criteria
* Subjects who are unlikely to complete taking the investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition.
* Pregnant or breast-feeding.
* Proven disability by law, such as blindness, deafness, dumb, disturbance of intelligence, mental disorders, limb handicap.
* Liable to be allergic (allergic to at lease 2 foods/drugs previously exposed)
* Had been participated in other clinical trials during the last 1 month prior to study inclusion.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sizuo
UNKNOWN
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nuerology, Kunming General Hospital of Chengdu Military Command
Kunming, Chengdu, China
Department of Nuerology, The Second People's Hospital of Foshan city
Foshan, Guangdong, China
Department of Nuerology, The Second People's Hospital of Jiangmen city
Jiangmen, Guangdong, China
Department of Nuerology, Liuzhou Hospital of Traditional Chinese Medicine
Liuzhou, Guangxi, China
Department of Nuerology, Cangzhou Central Hospistal
Cangzhou, Hebei, China
Department of Nuerology, Hubei Hospital of Traditional Chinese Medicine
Wuhan, Hubei, China
Department of Nuerology, The First People's Hospital of Changsha city
Changsha, Hunan, China
Department of Neurology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Department of Nuerology, Changzheng Hospital Affiliated to the Second Military Medical University
Shanghai, Shanghai Municipality, China
Department of Integrative Medicine, Zhongshan hospital, Fudan University
Shanghai, Shanghai Municipality, China
Department of Nuerology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
Department of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
Department of Nuerology, Zhongshan hospital, Fudan University
Shanghai, Shanghai Municipality, China
Department of Neurology, Huashan hospital, Fudan University
Shanghai, Shanghai Municipality, China
Department of Nuerology, Tongji Hospital of Tongji University
Shanghai, Shanghai Municipality, China
Department of Neurology, Shanghai First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Department of Nuerology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Department of Nuerology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Department of Neurology, Changhai Hospital Affiliated to the Second Military Medical University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shixiang Liu, MD
Role: primary
Qingkun Zhou, MD
Role: primary
Qiong Zheng, MD
Role: primary
Changjun Lu, MD
Role: primary
Junling Zhang, MD
Role: primary
Mengjiu Dong, MD
Role: primary
Shenhui Zhu, MD
Role: primary
Yansheng Li
Role: primary
Zhongxin Zhao, MD
Role: primary
Dingfang Cai
Role: primary
Zhenglong Fang, MD
Role: primary
Shengdi Chen, MD
Role: primary
Canxing Yuan, MD
Role: primary
Wei Fan, MD
Role: primary
Qiang Dong, MD
Role: primary
Qing Zhan, MD
Role: primary
Shaoshi Wang, MD
Role: primary
Zhenguo Liu, MD
Role: primary
Yangtai Guan, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XSCR capsule-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.